We could not find any results for:
Make sure your spelling is correct or try broadening your search.
WARREN, N.J., April 11, 2017 (GLOBE NEWSWIRE) -- MonoSol Rx, a specialty pharmaceutical company leveraging its PharmFilm® technology to develop and bring to market products that improve patient...
NEW YORK, Oct. 23 /PRNewswire/ -- HealthShares(TM) Inc., an investment company with a series of 20 underlying fund portfolios, today announced it has been informed by Standard & Poor's, the...
CAMBRIDGE, Mass., and NEW YORK, Oct. 22 /PRNewswire-FirstCall/ -- Genzyme Corporation (NASDAQ:GENZ) and Bioenvision, Inc. (NASDAQ:BIVN) announced this afternoon that Bioenvision stockholders...
Special Meeting to be Reconvened on October 22 NEW YORK and CAMBRIDGE, Mass., Oct. 10 /PRNewswire-FirstCall/ -- Bioenvision, Inc. (NASDAQ:BIVN) and Genzyme Corporation (NASDAQ:GENZ) announced...
CAMBRIDGE, Mass., Sept. 27 /PRNewswire-FirstCall/ -- Genzyme Corporation (NASDAQ:GENZ) confirmed today that it will not change its purchase price for Bioenvision (NASDAQ:BIVN) at $5.60 in cash...
Major Shareholder Will NOT Vote for Merger; Says 'Shareholders Have Already Spoken' by Rejecting Tender Offer at $5.60 per Share NEW YORK, Sept. 6 /PRNewswire-FirstCall/ -- Elliott Associates...
Bioenvision, Inc. (Nasdaq:BIVN) today announced an update on the status of its Marketing Authorization Application to the European Medicines Evaluation Agency (EMeA) to include...
OKLAHOMA CITY, July 27 /PRNewswire/ -- On July 13, 2007, a class action lawsuit was filed in the United States District Court for the Southern District of New York against Bioenvision, Inc...
Bioenvision, Inc. (Nasdaq:BIVN) today announced that it has been named as a defendant in a securities class action lawsuit filed in the United States District Court for the...
Bioenvision, Inc. (Nasdaq:BIVN) today announced that Dr. Andrew N. Schiff and Mr. Steven A. Elms have resigned from the Company?s Board of Directors effective as of July 13...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions